Alimera Sciences Investor Relations Material
Latest events
Q1 2024
Alimera Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Alimera Sciences Inc
Access all reports
Alimera Sciences Inc. is a pharmaceutical company focused on the development and commercialization of prescription ophthalmic treatments. The company specializes in therapies for retinal diseases, aiming to improve vision and quality of life for patients. The company is headquartered in Alpharetta, Georgia, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
ALIM
Country
🇺🇸 United States